Patent Application
20120050720
The present invention relates to a diagnostic system for observing pathological changes in the lipids in blood vessel using non-linear optical microscopy. More particularly, the present invention relates to a system for diagnosing the pathological change in lipids in blood vessels using Coherent Anti-strokes Raman Scattering microscopy which can image lipids abnormally deposited on the blood vessel intima and analyze the components of the imaged lipids, without labeling or destroying blood vessels, to diagnose minute pathological changes in the blood vessels, whereby the stage of progression of lipid-related diseases can be determined.
Lipids are associated with the various stages of arteriosclerosis progression. Lipid retention is regarded as an initial key event which has been implicated in the onset of arteriosclerosis. Although the so-called “response-to-retension” hypothesis has not been concretely verified, atherogenesis is induced by the accumulation of atherogenic lipoproteins in the intima. According to this model, once infiltrated into the intima, the lipoproteins combine with the extracellular matrix (ECM), chiefly with proteoglycans to create lipoprotein-proteoglycan complexes which induce atherogenic responses such as the recruitment of macrophages by secreted cytokines and lipid-laden foam cell differentiation. On the other hand, the content of lipids plays a critical role in determining the vulnerability of atheriosclerotic plaques in the late phase. Vulnerable plaques include the soft gruel phase of lipid-rich cores instead of hard collagen-rich cores. Indeed, several studies have reported that the lipid components of lesions are directly associated with the rupture of plaques and thrombosis. Advanced atheromatous cores contain cholesterols (both free and esterified types), phospholipids, triacylglycerols and fatty acids. In the atheromatous cores, the main component of cholesterol exist in crystallized forms with various appearances,such as plates, needles, and helices. In contrast to cellular membrane cholesterols, the crystalline cholesterols observed in advanced plaques are inert as extracellular lipids. Recently, Virmani et al. reported that ruptured plaques contain greater amounts of cholesterol clefts or crystals in necrotic cores than erosion or stable plaques from cross-sectioned coronary arteries, potentially indicating plaque vulnerability. Generally, the presence of atheriosclerotic lesions has been determined by evaluating narrowed arterial lumens rather than the morphology and chemical compositions of individual lesions mostly because there are no pertinent imaging modalities to perform the task. Conventionally, atherosclerosis has been diagnosed by systemic imaging in which luminal filling defects are read after the infusion of contrast media. Currently, because individual lesions are found to have heterogeneity, there is a need for imaging the vessel walls themselves. For the micropathological reading of vessel walls, current imaging techniques require tissue staining for micropathological reading, but this brings about damage to tissue. Further, the only images obtained are cross-sectional images from which it is very difficult to read pathological causes as existing in the tissue. In addition, there are no staining techniques which allow individual lipid components to be analyzed on images.
There are important criteria in diagnosing atherosclerosis. The earnest deposition of lipids is expedited by certain immune cells, e.g., macrophages. Activated macrophages contain excessive lipids and differentiate into foam cells. The appearance of foam cells is regarded as an important criterion for atherosclerosis. However, it is impossible for the current technology to visualize foam cells in tissues. Cholesterol exists as crystals in very advanced atherosclerosis. The amount of cholesterol crystals varies depending on the stage of advancement of atherosclerosis. It is also impossible for the current technology to image cholesterol crystals without destroying tissue.
Coherent Anti-stokes Raman Scattering (CARS) microcopy works by probing intrinsic molecular vibrations, which obviates the need to label target molecules and fix specimens. Thus, CARS microscopy has recently emerged as the most viable means for 3D chemical imaging of tissues. CARS microscopy has been used in the full-scale biological study of lipid metabolism in living organisms after direct evidence of the undesirable bias associated with fluorescence labeling techniques was demonstrated. Recently, a video-rate CARS microscopy system has been developed for imaging skin tissue in vivo. Because of the nonlinear nature of the CARS process, rapid scanning of the tight focal spot over the specimen permitted real-time acquisition of vibrational contrast images with 3D submicron resolution, which is not possible with conventional Raman microscopes. CARS microscopy is suitable for selective imaging of lipids because of the abundance of carbon-hydrogen (CH) bonds that exist in lipids as compared to the surrounding tissues. Lipids exhibit strong and distinct vibrational signatures in CARS spectra from 2700 to 3100 cm−1. However, detailed chemical analysis of the lipid composition is beyond mere vibrational histology and is still limited in the currently available CARS imaging modalities.
It is therefore an object to provide a system for diagnosing a micropathological change in lipids, which performs en face microscopic imaging to chemical compositions of atherosclerotic lipids, without labeling or destroying blood vessel intima.
It is another object of the present invention to provide a method for diagnosing a pathological change in the lipids in blood vessels using the system.
In order to accomplish the above objects, the present invention provides a system for diagnosing a pathological change of lipids in blood vessel, comprising:
a near infrared pulse laser unit for selectively illuminating Stokes beams, pump beams and probe beams to generate a combined laser beam, said Stokes beams, said pump beams and said probe beams being different in wavelength from one another;
a platform in which a sample is mounted, said sample being illuminated with the combined laser beam generated by the near-IR pulse laser unit;
a wideband multiplex CARS microspectrometer unit for collecting CARS signals generated from the sample to detect a spectrum;
an en face CARS image mode detection unit for collecting CARS signal generated from the sample to reconstruct a three-dimensional image; and,
a dichroic mirror, located between the wideband multiplex CARS microspectrometer unit and the en face CARS image mode detection unit, for selectively transferring the CARS signal generated from the sample into each unit.
Also, the present invention provides a method for diagnosing non-destructive pathological changes in the lipids in blood vessels, comprising:
illuminating a Stoke beam and a pump beam on a sample to generate a CARS (coherent anti-Stokes Raman scattering) lipid signal and measuring wavelength and intensity of the CARS signal;
constructing the signal as a three-dimensional image; and
analyzing structures of lipids from the image.
Also, the present invention provides a method for diagnosing a non-destructive, pathological change of lipids in the blood vessels, comprising:
illuminating a probe beam on a sample to generate CARS (coherent anti-Stokes Raman scattering) lipid signal and measuring wavelength and intensity of the CARS signal;
detecting the signal in a spectral pattern; and
analyzing structures of lipids from the spectral image.
The system and the method in accordance with the present invention can selectively image lipids without damage attributable to staining or destruction, or labeling, and thus can diagnose the stage of progression of atherosclerosis.
The present invention addresses a system for diagnosing a pathological change of lipids in blood vessels, comprising:
a near infrared pulse laser unit for selectively illuminating Stokes beams, pump beams and probe beams to generate a combined laser beam, said Stokes beams, said pump beams and said probe beams being different in wavelength from one another;
a platform in which a sample is mounted, said sample being illuminated with the combined laser beam generated by the near-IR pulse laser unit;
a wideband multiplex CARS microspectrometer unit for collecting CARS signals generated from the sample to detect a spectrum;
an en face CARS image mode detection unit for collecting CARS signal generated from the sample to reconstruct a three-dimensional image; and,
a dichroic mirror, located between the wideband multiplex CARS microspectrometer unit and the en face CARS image mode detection unit, for selectively transferring the CARS signal generated from the sample into each unit.
In an embodiment, the system of the present invention can perform lipid-selective 3D imaging and point-wise spectral analysis on the basis of C—H vibration in lipids, thereby constructing distinct images.
With reference to
The near IR pulse laser unit can generate a combined laser beam by selective illuminating Stokes beams, pump beams and probe beams which are different in wavelength from one another. The generated beams vibrate the C—H bonds in lipids to construct 3D images of the lipids, with a concomitant assessment of related Raman shifts.
For 3D imaging of lipids, Stokes beams and pump beams may be illuminated on a sample while probe beams may be blocked with a mechanical shutter upon 3D imaging because they are used to conduct spectral analysis of the lipids.
Preferably, the CARS signal of a lipid, obtained with the excitation beam of the near IR pulse laser unit, ranges in bandwidth from 2700 to 3050 cm1, which encompasses the entire CH stretching vibrations for 3D imaging.
In addition, the CARS signal is preferably collected at a rate of 1.0 s/frame, with a spatial resolution of 0.4 μm in a lateral plane and 1.3 μm along an axial (z) direction.
Further, the multiplex CARS microspectrometer unit functions to collect CARS signals generated from the sample and to detect spectra. An example is disclosed in Korean Patent Laid-Open Publication No. 2009-0024965, but is not limited thereto.
In the system of the present invention, the dichroic mirror is located between the wideband multiplex CARS microspectrometer unit and the en face CARS image mode detection unit and transfers the CARS signal generated from the same to each unit.
The dichroic mirror reflects wavelengths less than 1000 nm, but lets pass wavelengths of 1000 nm or greater.
After Stokes beams and pump beams are illuminated onto a sample, CARS lipid signals in the range of 645 to 675 nm are separated by a bandpass filter using the dichroic mirror and detected by the en face CARS imaging mode detection unit to provide a 3D image.
Further, for spectral analysis of lipids, the wideband multiplex CARS microphotometer unit is converted into a CARS measurement setup which is then illuminated with a probe beam for 50 to 150 ms with the laser-scanner adjusted in point-scan mode. As a result, a multiplex CARS signal is generated and passes through the grating monochromator to allow for spectral analysis. In this context, the probe beam preferably has a narrow band wavelength less than 3.5 cm−1 from which anti-Stokes signals may appear in the range of 620˜640 nm.
The sample used in the system for diagnosing a pathological change of lipids in blood vessels according to the present invention is not treated with any fixative or staining agents. So long as it is excised from animals, any tissue may be used in the present invention. For example, an animal cardiovascular tissue may be used in the present invention.
The thickness of the sample which can be analyzed with 3D imaging using the system of the present invention is on the order of 100˜150 μm.
Further, the pathological change in the lipids in blood vessels which can be diagnosed by the system of the present invention may be an atherosclerotic plaque.
As analyzed with the 3D images of lipids obtained by the system of the present invention, lipid droplets (foam cells) were observed in the superficial intima of a sample in the initial stage of atherosclerosis while the number of lipid droplets significantly increases, extracellular lipid deposits were embedded in the deep intima, and some lipid droplets were deposited on the well-defined multiple layers of plate-shaped crystallized lipids in the deep intima. In the advanced stage, the necrotic core had enlarged and was projected toward the lumen, crystallized lipid layers were predominantly imaged, and fibrous enlargement was observed.
The present invention also addresses a method for diagnosing non-destructive pathological changes in the lipids in blood vessels, comprising:
illuminating a Stoke beam and a pump beam on a sample to generate a CARS (coherent anti-Stokes Raman scattering) lipid signal and measuring wavelength and intensity of the CARS signal;
constructing the signal as a three-dimensional image; and
analyzing structures of lipids from the image.
The sample used in the system for diagnosing a pathological change in the lipids in blood vessels according to the present invention is not treated with any fixative or staining agents. So long as it is excised from animals, any tissue may be used in the present invention. For example, an animal cardiovascular tissue may be used in the present invention.
For 3D imaging, the signal is collected through a bandpass filter and detected by the en face CARS imaging mode detection unit.
In the 3D images, lipids in various structures are observed, for example, lipid droplets, plate- and needle-shapes crystals. When imaging animal atherosclerotic blood vessels, lipid structures are found to exist in various forms characteristic of the stage of progression of atherosclerosis. Further, volumes and sizes of lipids can also be analyzed. Accordingly, the stage of progression of atherosclerosis can be determined with the 3D images.
Also, the present invention addresses a method for diagnosing a non-destructive, pathological change of lipids in the blood vessels, comprising:
illuminating a probe beam on a sample to generate CARS (coherent anti-Stokes Raman scattering) lipid signal and measuring wavelength and intensity of the CARS signal;
detecting the signal in a spectral pattern; and
analyzing structures of lipids from the spectral image.
The sample used in the system for diagnosing pathological change of lipids in blood vessels according to the present invention is not treated with any fixative or staining agents. So long as it is excised from animals, any tissue may be used in the present invention. For example, an animal cardiovascular tissue may be used in the present invention.
The signal passes through a grating monochromator and can be detected in a spectral pattern by the wideband multiplex CARS microspectrometer unit.
In the spectrum, both extracellular lipid droplets in the ECM and intracellular lipid droplets from lipid-laden foam cells exhibit one main peak (2845 cm−1). The plate-shaped lipid crystal exhibits four extra peaks at 2880, 2905, 2920 and 2950 cm−1 on the CARS spectrum. The needle-shaped crystallized lipids showed weaker peaks at 2905, 2920 and 2950 cm−1. These peaks reflected pathological changes in the lipids.
Therefore, the chemical profiles of lipids can be applied to the determination of the stage of progression of atherosclerosis.
A better understanding of the present invention may be obtained through the following examples which are set forth to illustrate, but are not to be construed as limiting the present invention.
For lipid-selective 3-D microscopic imaging and point-wise spectral analysis of cardiovascular tissues having atherosclerotic lesions, a wideband multiplex CARS microspectrometer and laser-scanning CARS microscope were concurrently set on the same platform.
As shown in
In summary, label-free, lipid-selective chemical imaging is implemented with a CARS platform covering the Raman shift from 2700 to 3050 cm−1 in which the bandwidth of the beams used is expanded to allow multiplex access to the entire CR stretching vibration in the range of 2700-3050 cm−1, so that atherosclerotic lipids can be visualized and chemically analyzed. Next, The CARS microscopy setup could acquire two dimensional (2D) en-face images having a maximum field of view of 250×250 μm2 with a spatial resolution of 0.4 μm in the lateral (x-y) plane and 1.3 μm along the axial (z) direction, and obtain image slices at a frame rate of 1.0 s/frame, which is improved compared to typical Raman microscopes for label-free bio-imaging. Finally, the CARS microscope can be readily converted to a wideband multiplex CARS setup used for the spectral analysis of atherosclerotic lipids. After lipid-selective 3D imaging, sites suitable for CARS spectral analysis are selected and exposed for 50˜150 ms before analysis.
(Sample Preparation)
For use as samples, Carotid endarterectomy specimens were obtained from patients with carotid artery stenosis (aged 63-81 yr) who underwent surgery at Samsung Medical Center (SMC). The specimens were immediately immersed in phosphate-buffered saline (PBS) and delivered for CARS analysis. Two internal mammary artery specimens were also obtained from coronary artery bypass graft patients for use as reference. This study was approved by the Institutional Review Committee at SMC, complying with the Declaration of Helsinki guidelines, and informed consent was obtained from all subjects (IRB 2006-02-011).
(Animal Test)
Apolipoprotein E knock-out (ApoE−/−) mice were purchased from the Jackson Laboratory (Bar Harbor, Me.) and adapted for one week at the Samsung Biomedical Research Institute under specific pathogen-free conditions. Eight-week-old male ApoE−/− mice were fed on a 0.15% high-fat high-cholesterol (HFHC) diet (n=22) for 2-20 weeks (CRF-1; Research Diets, Inc., New Brunswick, N.J.). Mice fed normal chow were used as reference. Every other week after 2 weeks, 4-6 mice were sacrificed with CO2 inhalation. The heart and aorta were perfused with PBS for 10 min and then promptly removed for CARS imaging. All animal studies conformed with the Institutional Animal Care and Use Committee of Samsung Biomedical Research Institute.
(Sample Preparation for Ex Vivo CARS Imaging)
After harvesting the heart and aortas, the samples were prepared for CARS imaging. The connective tissue of the aorta was carefully removed and the aorta was stored in cold PBS to allow analysis of its lipid chemical profile by CARS. The aortas were incised longitudinally from the ascending aorta to the thoracic descending aorta and dissected into four segments for further assessment as follows: 1) the aorta segment containing the lesser curvature of the aortic arch, 2) the aorta segment containing the innominate artery, 3) the aorta segment containing the left common carotid and left subclavian arteries, and 4) the segment of the thoracic descending aorta. Prepared segments were mounted lumen-side down on a coverslip using PBS with no chemical mounting solution or fixatives for subsequent CARS study.
(Statistics)
Image analysis was performed using Image-Pro software (Media Cybernetics, Inc., Bethesda, Md.). All imaging analyses of optical density measurements were conducted in triplicate to minimize the deviations of each case. All probabilities were compared using Student's t-test. All p-values less than 0.05 were considered statistically significant.
En face chemical imaging of mouse and human atherosclerotic plaques was performed using the CARS microscope of Example 1. After whole aortas were harvested from atherosclerotic ApoE−/− mice (n=28), the lesser curvature of the aortic arch and the carotid artery was longitudinally incised and imaged by CARS, without the use of fixatives.
As can be seen in the semi-spherical 3D CARS image of a single atherosclerotic plaque of
To investigate the medical applicability thereof, CARS microscopy was applied to the human atherosclerotic carotid artery using the same imaging protocol (
To assess the progression of atherosclerosis using the CARS imaging platform of Example 1, various levels of atherosclerotic plaques were obtained from ApoE−/− mice (n=28) fed with a high-fat diet for 2 to 20 weeks. As a control, ApoE−/− mice fed with a normal chow diet were assessed at the same time points. Every week, serial en face CARS imaging was performed in mouse aortas. The progression of atherosclerosis was analyzed using CARS images taken for the vertical infiltration of lipids across the aortic wall and the morphological change of lipid structures.
In the 2-week-old atherosclerosis mouse models, few of the imaged lipid droplets were bound to the extracellular matrix (ECM) (
Using 3D CARS imaging, lipid distribution was quantified in three main stages (initial, intermediate and advanced stages:
The progression of atherosclerosis was analyzed by quantifying accumulated lipids at 3 stages depending on the period of high-fat diet consumption. During the initial stage (weeks 2-6,
In addition, as a result of the comparison of lipid distributions in i-iv of
Chemical differences among various types of atherosclerotic lipids were analyzed on the basis of spectral patterns using multiplex CARS. Depending on the morphological differences of the en face images, the analyzed lipids were classified into four main categories, that is, extracellular and intracellular lipid droplets, and plate- and needle-shaped lipids.
The spectra of both extracellular lipid droplets in the ECM and intracellular lipid droplets from lipid-laden foam cells exhibited one main peak (2845 cm−1) resonating at the symmetrical CH2 vibration. The chemical profile of the plate-shaped lipid crystal, however, was significantly different from that of lipid droplets, because it exhibited 4 extra peaks at 2880, 2905, 2920 and 2950 cm−1 on the CARS spectrum. The extra peaks were assigned as CH2 asymmetrical, CH3 symmetrical, and CH3 asymmetrical vibrations, respectively. Conversely, the needle-shaped crystallized lipids showed weaker peaks at 2905, 2920 and 2950 cm−1 as compared to the spectra of plate-shaped lipid crystals. The penetration depth of lipid-crystal structures was analyzed over a wide area. The resulting spectra were highly reproducible based on the appearance of the lipids, irrespective of their depth (n=187).
Having the ability to selectively image lipids without damage attributable to staining, destruction or labeling, the system and the method of the present invention can diagnose the stage of progression of atherosclerosis and find useful applications in the medical instrument industry.
Although the preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/KR2009/002478 | 5/11/2009 | WO | 00 | 11/10/2011 |
